John A. Belperio, MD

John Belperio, MD

Professor, Department of Medicine, Pulmonary and Critical Care




Medicine, Pulmonary Disease

Institutional Affiliation

Ronald Reagan UCLA Medical Center



Pulmonary and Critical Care Medicine, University of Michigan Health System, 1997 - 2000


Internal Medicine, University of Maryland at Baltimore, 1994 - 1995


MD, Temple University School of Medicine, 1994


Internal Medicine, University of Maryland at Baltimore, 1995 - 1997

Board Certifications

Internal Medicine, American Board of Internal Medicine, 1997, 2010
Critical Care Medicine, American Board of Internal Medicine, 2000, 2010
Pulmonary Disease, American Board of Internal Medicine, 1999, 2010

Contact Information

Clinical Interests

Critical Care, Cystic Fibrosis, General Pulmonology, Interstitial and Parenchymal Lung Disease, Pulmonary Fibrosis, Pulmonary Procedures, Sleep Disorders

Scientific Interests

Dr. John Belperio's research focuses on 1) lung transplant tolerance to avoid skin cancers post-transplant and 2) pulmonary fibrosis immune mechanisms and how they support lung cancer.

Highlighted Publications

Kolaitis NA, Duffy E, Zhang A, Lo M, Barba DT, Chen M, Soriano T, Hu J, Nabili V, Saggar R, Sayah DM, DerHovanessian A, Shino MY, Lynch JP 3rd, Kubak BM, Ardehali A, Ross DJ, Belperio JA, Elashoff D, Saggar R, Weigt SS. Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation. Transpl Int. 2017 Jan;30(1):41-48. doi: 10.1111/tri.12865. Epub 2016 Oct 24.

Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer. 2006 Apr;42(6):768-78. Epub 2006 Feb 28. Review.

Pan J, Burdick MD, Belperio JA, Xue YY, Gerard C, Sharma S, Dubinett SM, Strieter RM. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis. J Immunol. 2006 Feb 1;176(3):1456-64.